US Map / Alabama
State AL

Clinical Trials in Alabama

Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.

Total Trials
179
Recruiting Now
179
← Back to US Map
Top Conditions in Alabama
Heart Failure (3)Endometrial Cancer (3)Multiple Myeloma (3)Breast Cancer (3)Sickle Cell Disease (3)Atopic Dermatitis (3)Cardiovascular Diseases (3)Rheumatoid Arthritis (2)Systemic Lupus Erythematosus (2)Non Small Cell Lung Cancer (2)Genetic Disease (2)Ovarian Cancer (2)

Frequently Asked Questions — Clinical Trials in Alabama

How many clinical trials are currently recruiting in Alabama?
ClinicalMetric currently tracks 179 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 179. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alabama?
Alabama hosts clinical trials across a broad range of medical conditions, including Heart Failure, Endometrial Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alabama?
To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Alabama

NCT06188585 N/A
Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal U...
Condition
Acute Gastrointestinal Bleeding
Enrollment
278 pts
Location
United States, Canada, Denmark
Sponsor
Medtronic - MITG
View Trial →
NCT07201558 Phase 1
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE P...
Condition
Rheumatoid Arthritis
Enrollment
48 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
View Trial →
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05465174 Phase 2
Recruiting
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Condition
Craniopharyngioma, Child
Enrollment
57 pts
Location
United States, Australia
Sponsor
Sabine Mueller, MD, PhD
View Trial →
NCT06346392 Phase 3
Recruiting
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Seco...
Condition
Gastric Cancer
Enrollment
572 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT06538038 N/A
Recruiting
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for ...
Condition
Non Small Cell Lung Cancer
Enrollment
538 pts
Location
United States
Sponsor
PrECOG, LLC.
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
View Trial →
NCT06274112 N/A
Recruiting
Using TMS to Understand Neural Processes of Social Motivation
Condition
Social Avoidant Behavior
Enrollment
40 pts
Location
United States
Sponsor
Auburn University
View Trial →
NCT06220201 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97...
Condition
Multiple Sclerosis
Enrollment
120 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
View Trial →
NCT07474792 Phase 2
Recruiting
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoria...
Condition
Plaque Psoriasis
Enrollment
160 pts
Location
United States, Canada
Sponsor
Oruka Therapeutics, Inc.
View Trial →
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
View Trial →
NCT07553637 Phase 2
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Condition
Treatment-resistant Depression (TRD)
Enrollment
178 pts
Location
United States, United Kingdom
Sponsor
Alto Neuroscience
View Trial →
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
View Trial →
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT06169852 N/A
Recruiting
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal D...
Condition
Parkinson Disease
Enrollment
36 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT06237335 Phase 2
Recruiting
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Hea...
Condition
Cystic Fibrosis
Enrollment
192 pts
Location
United States, France, Netherlands
Sponsor
ReCode Therapeutics
View Trial →
NCT05432349 N/A
Recruiting
Rett Syndrome Registry
Condition
Rett Syndrome
Enrollment
3,000 pts
Location
United States
Sponsor
International Rett Syndrome Fo
View Trial →
NCT04657068 Phase 1, Phase 2
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
442 pts
Location
United States, France, Spain
Sponsor
Artios Pharma Ltd
View Trial →
NCT06948214 Phase 3
Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Condition
Growth Hormone Deficiency (GHD)
Enrollment
150 pts
Location
United States, Australia, New Zealand
Sponsor
Lumos Pharma
View Trial →
NCT06793397 Phase 3
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive...
Condition
Major Depressive Disorder (MDD)
Enrollment
330 pts
Location
United States, Australia, Czechia
Sponsor
Cybin IRL Limited
View Trial →
NCT06472206 N/A
Recruiting
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
Condition
HIV/AIDS
Enrollment
420 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT06455085 N/A
Recruiting
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Condition
Osteoporosis
Enrollment
2,634 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT06958211 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants W...
Condition
Hidradenitis Suppurativa
Enrollment
550 pts
Location
United States, Belgium, Bulgaria
Sponsor
Incyte Corporation
View Trial →
NCT04042844 Phase 2
Recruiting
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition
Lumbar Disc Disease
Enrollment
99 pts
Location
United States
Sponsor
BioRestorative Therapies
View Trial →
Page 1 of 8 — 179 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology